139 related articles for article (PubMed ID: 32662649)
1. Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand.
Liu L; Prime ME; Lee MR; Khetarpal V; Brown CJ; Johnson PD; Miranda-Azpiazu P; Chen X; Clark-Frew D; Coe S; Davis R; Dickie A; Ebneth A; Esposito S; Gadouleau E; Gai X; Galan S; Green S; Greenaway C; Giles P; Halldin C; Hayes S; Herbst T; Herrmann F; Heßmann M; Jia Z; Kiselyov A; Kotey A; Krulle T; Mangette JE; Marston RW; Menta S; Mills MR; Monteagudo E; Nag S; Nibbio M; Orsatti L; Schaertl S; Scheich C; Sproston J; Stepanov V; Svedberg M; Takano A; Taylor M; Thomas W; Toth M; Vaidya D; Vanräs K; Weddell D; Wigginton I; Wityak J; Mrzljak L; Munoz-Sanjuan I; Bard JA; Dominguez C
J Med Chem; 2020 Aug; 63(15):8608-8633. PubMed ID: 32662649
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidates.
Herrmann F; Hessmann M; Schaertl S; Berg-Rosseburg K; Brown CJ; Bursow G; Chiki A; Ebneth A; Gehrmann M; Hoeschen N; Hotze M; Jahn S; Johnson PD; Khetarpal V; Kiselyov A; Kottig K; Ladewig S; Lashuel H; Letschert S; Mills MR; Petersen K; Prime ME; Scheich C; Schmiedel G; Wityak J; Liu L; Dominguez C; Muñoz-Sanjuán I; Bard JA
Sci Rep; 2021 Sep; 11(1):17977. PubMed ID: 34504195
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using
Bertoglio D; Weiss AR; Liguore W; Martin LD; Hobbs T; Templon J; Srinivasan S; Dominguez C; Munoz-Sanjuan I; Khetarpal V; Verhaeghe J; Staelens S; Link J; Liu L; Bard JA; McBride JL
J Nucl Med; 2023 Oct; 64(10):1581-1587. PubMed ID: 37591545
[TBL] [Abstract][Full Text] [Related]
4. Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease.
Bertoglio D; Bard J; Hessmann M; Liu L; Gärtner A; De Lombaerde S; Huscher B; Zajicek F; Miranda A; Peters F; Herrmann F; Schaertl S; Vasilkovska T; Brown CJ; Johnson PD; Prime ME; Mills MR; Van der Linden A; Mrzljak L; Khetarpal V; Wang Y; Marchionini DM; Skinbjerg M; Verhaeghe J; Dominguez C; Staelens S; Munoz-Sanjuan I
Sci Transl Med; 2022 Feb; 14(630):eabm3682. PubMed ID: 35108063
[TBL] [Abstract][Full Text] [Related]
5. [
Liu L; Johnson PD; Prime ME; Khetarpal V; Lee MR; Brown CJ; Chen X; Clark-Frew D; Coe S; Conlon M; Davis R; Ensor S; Esposito S; Moren AF; Gai X; Green S; Greenaway C; Haber J; Halldin C; Hayes S; Herbst T; Herrmann F; Heßmann M; Hsai MM; Kotey A; Mangette JE; Mills MR; Monteagudo E; Nag S; Nibbio M; Orsatti L; Schaertl S; Scheich C; Sproston J; Stepanov V; Varnäs K; Varrone A; Wityak J; Mrzljak L; Munoz-Sanjuan I; Bard JA; Dominguez C
J Med Chem; 2021 Aug; 64(16):12003-12021. PubMed ID: 34351166
[TBL] [Abstract][Full Text] [Related]
6. PET Ligands for Imaging Mutant Huntingtin Aggregates: A Case Study in Non-For-Profit Scientific Management.
Dickmann CGF; Milicevic Sephton S; Barker RA; Aigbirhio FI
Chembiochem; 2024 Jun; 25(11):e202400152. PubMed ID: 38695673
[TBL] [Abstract][Full Text] [Related]
7. A Filter Retardation Assay Facilitates the Detection and Quantification of Heat-Stable, Amyloidogenic Mutant Huntingtin Aggregates in Complex Biosamples.
Ast A; Schindler F; Buntru A; Schnoegl S; Wanker EE
Methods Mol Biol; 2018; 1780():31-40. PubMed ID: 29856013
[TBL] [Abstract][Full Text] [Related]
8. Design and Evaluation of [
Liu L; Johnson PD; Prime ME; Khetarpal V; Brown CJ; Anzillotti L; Bertoglio D; Chen X; Coe S; Davis R; Dickie AP; Esposito S; Gadouleau E; Giles PR; Greenaway C; Haber J; Halldin C; Haller S; Hayes S; Herbst T; Herrmann F; Heßmann M; Hsai MM; Khani Y; Kotey A; Lembo A; Mangette JE; Marriner GA; Marston RW; Mills MR; Monteagudo E; Forsberg-Morén A; Nag S; Orsatti L; Sandiego C; Schaertl S; Sproston J; Staelens S; Tookey J; Turner PA; Vecchi A; Veneziano M; Muñoz-Sanjuan I; Bard J; Dominguez C
J Med Chem; 2023 Jan; 66(1):641-656. PubMed ID: 36548390
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's disease.
Bertoglio D; Verhaeghe J; Miranda A; Wyffels L; Stroobants S; Mrzljak L; Khetarpal V; Skinbjerg M; Liu L; Dominguez C; Munoz-Sanjuan I; Bard J; Staelens S
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1166-1175. PubMed ID: 34651228
[TBL] [Abstract][Full Text] [Related]
10. Cryo-electron tomography provides topological insights into mutant huntingtin exon 1 and polyQ aggregates.
Galaz-Montoya JG; Shahmoradian SH; Shen K; Frydman J; Chiu W
Commun Biol; 2021 Jul; 4(1):849. PubMed ID: 34239038
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Multidimensional Brain Imaging in Huntington's Disease Animal Models.
Flament J; Hantraye P; Valette J
Methods Mol Biol; 2018; 1780():285-301. PubMed ID: 29856025
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease.
Ban JJ; Chung JY; Lee M; Im W; Kim M
Biochem Biophys Res Commun; 2017 Jun; 488(2):316-321. PubMed ID: 28495533
[TBL] [Abstract][Full Text] [Related]
13. Effects of Exogenous NUB1 Expression in the Striatum of HDQ175/Q7 Mice.
Vodicka P; Chase K; Iuliano M; Valentine DT; Sapp E; Lu B; Kegel-Gleason KB; Sena-Esteves M; Aronin N; DiFiglia M
J Huntingtons Dis; 2016 Jun; 5(2):163-74. PubMed ID: 27314618
[TBL] [Abstract][Full Text] [Related]
14. Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin.
Tan Z; Dai W; van Erp TG; Overman J; Demuro A; Digman MA; Hatami A; Albay R; Sontag EM; Potkin KT; Ling S; Macciardi F; Bunney WE; Long JD; Paulsen JS; Ringman JM; Parker I; Glabe C; Thompson LM; Chiu W; Potkin SG
Mol Psychiatry; 2015 Nov; 20(11):1286-93. PubMed ID: 26100538
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates.
Gosset P; Maxan A; Alpaugh M; Breger L; Dehay B; Tao Z; Ling Z; Qin C; Cisbani G; Fortin N; Vonsattel JG; Lacroix S; Oueslati A; Bezard E; Cicchetti F
Neurobiol Dis; 2020 Jul; 141():104941. PubMed ID: 32422281
[TBL] [Abstract][Full Text] [Related]
16. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
[TBL] [Abstract][Full Text] [Related]
17. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.
Davranche A; Aviolat H; Zeder-Lutz G; Busso D; Altschuh D; Trottier Y; Klein FA
Hum Mol Genet; 2011 Jul; 20(14):2795-806. PubMed ID: 21518730
[TBL] [Abstract][Full Text] [Related]
18. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
Hong Y; Zhao T; Li XJ; Li S
J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
[TBL] [Abstract][Full Text] [Related]
19. TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
Simmons DA; James ML; Belichenko NP; Semaan S; Condon C; Kuan J; Shuhendler AJ; Miao Z; Chin FT; Longo FM
Hum Mol Genet; 2018 Aug; 27(16):2893-2912. PubMed ID: 29860333
[TBL] [Abstract][Full Text] [Related]
20. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
